ISRIB

From Wikipedia, the free encyclopedia
Jump to: navigation, search
ISRIB
ISRIB structure.png
Systematic (IUPAC) name
trans-N,N'-(cyclohexane-1,4-diyl)bis(2-(4-chlorophenoxy)acetamide)
Clinical data
Legal status
?
Identifiers
CAS number  YesY
ATC code None
Chemical data
Formula C22H24Cl2N2O4 
Molecular mass 451.34 g/mol

ISRIB, (an acronym for Integrated Stress Response inhibitor), is an experimental drug which reverses the effects of eIF2α phosphorylation with an IC50 of 5nM. It was discovered by a group at the University of California through a semi-automated screening of a large library of small molecules. Since eIF2α phosphorylation is known to be involved in memory formation, ISRIB was tested to see whether it would be active in vivo, and was found to readily cross the blood-brain barrier, with a half-life of 8 hours. Subsequent testing found ISRIB to produce significant nootropic effects in mice, as measured by enhancement of spatial and fear-associated learning in standard water maze and conditioned environment tests.[1]

See also[edit]

References[edit]

  1. ^ Sidrauski, C.; Acosta-Alvear, D.; Khoutorsky, A.; Vedantham, P.; Hearn, B. R.; Li, H.; Gamache, K.; Gallagher, C. M.; Ang, K. K. -H.; Wilson, C.; Okreglak, V.; Ashkenazi, A.; Hann, B.; Nader, K.; Arkin, M. R.; Renslo, A. R.; Sonenberg, N.; Walter, P. (2013). "Pharmacological brake-release of mRNA translation enhances cognitive memory". ELife 2: e00498. doi:10.7554/eLife.00498. PMC 3667625. PMID 23741617.  edit